The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer

NCT02243618 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenoma
Early Gastric Cancer

Interventions

DRUG: Polaprezinc
DRUG: Rebamipide

Sponsor

Yonsei University